Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Ambrx of San Diego Acquired by Fosun Pharma, WuXi PharmaTech and Others

publication date: May 22, 2015
Ambrx Inc., a clinical-stage San Diego antibody-conjugate biotech company, will be acquired by a consortium of China companies, including Fosun Pharma and WuXi PharmaTech, plus China equity investors HOPU and Everbright. The price was not disclosed. Last year, Ambrx filed for an IPO that valued the company at $223 million, but withdrew the offering. Ambrx, which has raised around $100 million of venture capital, has attracted many big names for partners, bringing in $200 million in deal payments. Its partnerships contain milestones that could total as much as $1.5 billion. More details....

Stock Symbols: (SHA: 600196; HK: 02196) (NYSE: WX)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here